Human Molecular Genetics Advance Access originally published online on June 9, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Human Molecular Genetics, 2004, Vol. 13, No. 15 1577-1585
DOI: 10.1093/hmg/ddh176
Human Molecular Genetics, Vol. 13, No. 15 © Oxford University Press 2004; all rights reserved
Full spectrum of malformations in velo-cardio-facial syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosage
1Department of Molecular Genetics, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA, 2Department of Pediatrics, Brown University Medical School, Providence, RI 02912, USA, 3Departments of Medicine and Cell and Developmental Biology, University of Pennsylvania, 954 Biomedical Research Building (BRB) II/III, 421 Curie Boulevard, Philadelphia, PA 19104, USA and 4Department of Otology and Laryngology, Harvard Medical School, Eaton-Peabody Laboratory, Massachusetts Eye and Ear Infirmary, 243 Charles Street, Boston, MA 02114, USA
Received March 22, 2004; Accepted May 26, 2004
Velo-cardio-facial syndrome/DiGeorge syndrome (VCFS/DGS) is associated with de novo hemizygous 22q11.2 deletions and is characterized by malformations attributed to abnormal development of the pharyngeal arches and pouches. The main physical findings include aortic arch and outflow tract heart defects, thymus gland hypoplasia or aplasia and craniofacial anomalies. The disorder varies greatly in expressivity; while some patients are mildly affected with learning disabilities and subtle craniofacial malformations, others die soon after birth with major cardiovascular defects and thymus gland aplasia. In addition to the main clinical features, many other findings are associated with the disorder such as chronic otitis media and hypocalcemia. Tbx1, a gene encoding a T-box transcription factor, which is hemizygously deleted on chromosome 22q11.2, was found to be a strong candidate for the equivalent of human VCFS/DGS in mice. Mice hemizygous for a null allele of Tbx1 had mild malformations, while homozygotes had severe malformations in the affected structures; neither precisely modeling the syndrome. Interestingly, bacterial artificial chromosome (BAC) transgenic mice overexpressing human TBX1 and three other transgenes, had similar malformations as VCFS/DGS patients. By employing genetic complementation studies, we demonstrate that altered TBX1 dosage and not overexpression of the other transgenes is responsible for most of the defects in the BAC transgenic mice. Furthermore, the full spectrum of VCFS/DGS malformations was elicited in a Tbx1 dose dependent manner, thus providing a molecular basis for the pathogenesis and varied expressivity of the syndrome.
* To whom correspondence should be addressed at: Department of Molecular Genetics, Albert Einstein College of Medicine, Ullmann Building, Room 1217, 1300 Morris Park Avenue, Bronx, NY 10461, USA. Tel: +1 7184304274; Fax: +1 7184308778; Email: morrow{at}aecom.yu.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Coppinger, D. McDonald-McGinn, E. Zackai, K. Shane, J. F. Atkin, A. Asamoah, R. Leland, D. D. Weaver, S. Lansky-Shafer, K. Schmidt, et al. Identification of familial and de novo microduplications of 22q11.21-q11.23 distal to the 22q11.21 microdeletion syndrome region Hum. Mol. Genet., April 15, 2009; 18(8): 1377 - 1383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zhang, Y. Lin, Y. Zhang, Y. Lan, C. Lin, A. M. Moon, R. J. Schwartz, J. F. Martin, and F. Wang Frs2{alpha}-deficiency in cardiac progenitors disrupts a subset of FGF signals required for outflow tract morphogenesis Development, November 1, 2008; 135(21): 3611 - 3622. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Cerbai and L. Sartiani Holt-Oram Syndrome and Atrial Fibrillation: Opening the (T)-Box Circ. Res., June 6, 2008; 102(11): 1304 - 1306. [Full Text] [PDF]
|
|
|
|
|
|
Z. Zhang and A. Baldini In vivo response to high-resolution variation of Tbx1 mRNA dosage Hum. Mol. Genet., January 1, 2008; 17(1): 150 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Fagman, J. Liao, J. Westerlund, L. Andersson, B.E. Morrow, and M. Nilsson The 22q11 deletion syndrome candidate gene Tbx1 determines thyroid size and positioning Hum. Mol. Genet., February 1, 2007; 16(3): 276 - 285. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. S. Aggarwal, J. Liao, A. Bondarev, T. Schimmang, M. Lewandoski, J. Locker, A. Shanske, M. Campione, and B. E. Morrow Dissection of Tbx1 and Fgf interactions in mouse models of 22q11DS suggests functional redundancy Hum. Mol. Genet., November 1, 2006; 15(21): 3219 - 3228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Zhang, T. Huynh, and A. Baldini Mesodermal expression of Tbx1 is necessary and sufficient for pharyngeal arch and cardiac outflow tract development Development, September 15, 2006; 133(18): 3587 - 3595. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Arnold, E. M. Braunstein, T. Ohyama, A. K. Groves, J. C. Adams, M. C. Brown, and B. E. Morrow Tissue-specific roles of Tbx1 in the development of the outer, middle and inner ear, defective in 22q11DS patients Hum. Mol. Genet., May 15, 2006; 15(10): 1629 - 1639. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nowotschin, J. Liao, P. J. Gage, J. A. Epstein, M. Campione, and B. E. Morrow Tbx1 affects asymmetric cardiac morphogenesis by regulating Pitx2 in the secondary heart field. Development, April 1, 2006; 133(8): 1565 - 1573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Arnold, U. Werling, E. M. Braunstein, J. Liao, S. Nowotschin, W. Edelmann, J. M. Hebert, and B. E. Morrow Inactivation of Tbx1 in the pharyngeal endoderm results in 22q11DS malformations Development, March 1, 2006; 133(5): 977 - 987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Hiroi, H. Zhu, M. Lee, B. Funke, M. Arai, M. Itokawa, R. Kucherlapati, B. Morrow, T. Sawamura, and S. Agatsuma A 200-kb region of human chromosome 22q11.2 confers antipsychotic-responsive behavioral abnormalities in mice PNAS, December 27, 2005; 102(52): 19132 - 19137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Pizard, P. G. Burgon, D. L. Paul, B. G. Bruneau, C. E. Seidman, and J. G. Seidman Connexin 40, a Target of Transcription Factor Tbx5, Patterns Wrist, Digits, and Sternum Mol. Cell. Biol., June 15, 2005; 25(12): 5073 - 5083. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Z. Stoller and J. A. Epstein Identification of a novel nuclear localization signal in Tbx1 that is deleted in DiGeorge syndrome patients harboring the 1223delC mutation Hum. Mol. Genet., April 1, 2005; 14(7): 885 - 892. [Abstract] [Full Text] [PDF]
|
|